Results 121 to 130 of about 5,328 (181)

Evolving Therapeutic Landscape of ROS1-Positive Non-Small Cell Lung Cancer: An Updated Review. [PDF]

Curr Oncol
Bischoff H, Gendarme S, Somme L, Chouaid C, Schott R.   +4 more
europepmc   +1 more source

Dissociation Between Tumor Response and PTTM Progression During Entrectinib Therapy in NTRK Fusion-Positive Colon Cancer. [PDF]

Curr Oncol
Nagano H, Ohyama S, Sato A, Igarashi J, Yamamoto T, Kobayashi M.   +5 more
europepmc   +1 more source

Hepatotoxicity of ALK/ROS1 tyrosine kinase inhibitors in non-small cell lung cancer patients: A pharmacovigilance study based on signal mining and analysis of the FDA adverse event reporting system database. [PDF]

Sci Prog
Zhao W, Jin X, Li Y, Peng H, Jiang J.
europepmc   +1 more source

In silico & in vitro approaches suggest osteoclastogenesis induction underlying fractures in Entrectinib-treated children. [PDF]

Arch Toxicol
Ehnert S, Nüssler AK, Schulz KA, Cardenas A, Meneses-Lorente G, McCallum S, Fürst-Recktenwald S, Roth A.   +7 more
europepmc   +1 more source

Adopting life-cycle HTA: a tumor-agnostic precision oncology index economic evaluation from publicly available reimbursement reviews. [PDF]

Int J Technol Assess Health Care
Cupples G, Krebs E, Weymann D, Ho C, Regier DA.   +4 more
europepmc   +1 more source

Computational studies on structural aspects of pyrazolo[3,4-b]pyridine derivatives as TRKA inhibitors in cancer therapy. [PDF]

Sci Rep
Gheidari D, Mehrdad M, Jani K, Feizkhah A.   +3 more
europepmc   +1 more source

Toxicity profiles of ROS1 tyrosine kinase inhibitors in advanced non-small cell lung cancer: a systematic review and proportional meta-analysis. [PDF]

Front Pharmacol
Jiang BX, Zeng JW, Yan JJ, Zhao LY.
europepmc   +1 more source

Case Report: Dramatic response to entritinib in a patient with gastrointestinal stromal tumor positive for <i>NTRK3</i> fusion. [PDF]

Front Oncol
Dong G, Han P, Zhang Z, Ge Q, Jiang J, Li S, Ma J, Bai J, Wei H, Zhao Z.   +9 more
europepmc   +1 more source

How I treat NTRK gene fusion-positive cancers [PDF]

, 2019
Lassen, Ulrik
core   +1 more source

In-silico discovery of druggable molecular signatures that drive dengue fever to severe dengue fever highlighting common pathogenesis through single-cell RNA-Seq analysis. [PDF]

Sci Rep
Al Noman M, Latif MA, Ahmed MF, Islam MS, Al Amin Pappu M, Hossain MS, Hossen MB, Noor T, Mollah MMH, Kabir MH, Mollah MNH.   +10 more
europepmc   +1 more source